The Graft versus Host Disease (GvHD) treatment market is poised for significant advancement, with a projected CAGR of 8.50% during 2025–2034. This growth is supported by continuous developments in therapeutic options, increasing clinical research activity, and improved diagnosis rates across major global markets. As more healthcare providers focus on managing transplant-related compli... https://www.expertmarketresearch.com/reports/graft-versus-host-disease-treatment-market